Oxaltero Oxaliplatin 50mg Injection

Name: Oxaltero Oxaliplatin 50mg Injection
Brand: K T Agencies
Price: 2345.0 INR
Availability: InStock

Price 2345.0 INR/ Bottle

Get a Price/Quote

MOQ : 100 Packs

Oxaltero Oxaliplatin 50mg Injection Specification

Indication
Cancer treatment

Dosage Form
Injection

Origin
India

Salt Composition
Oxaliplatin

Storage Instructions
Cool and dry place

Shelf Life
12 Months

Oxaltero Oxaliplatin 50mg Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
7-10 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Oxaltero Oxaliplatin 50mg Injection

Oxaltero Oxaliplatin 50mg Injection is a popular, in-demand cancer treatment recognized for its ineffable efficacy and distinguished record among oncology specialists. Originating from India, this lofty pharmaceutical solution contains Oxaliplatin as its key active salt, precisely formulated for intravenous administration. As a limited stock item, it appeals to discerning exporters and suppliers seeking reliable inventory. With a shelf life of 12 months, Oxaltero Oxaliplatin maintains its potency when stored in a cool, dry place, ensuring patients receive optimal therapeutic benefits and consistent quality for cancer care.

Oxaltero Oxaliplatin 50mg Injection: Usage & Advantages

This injection is primarily prescribed for cancer treatment, administered under medical supervision for optimal results. Patients are advised to follow precise directions of use provided by healthcare professionals. Distinguished by its reliance on Oxaliplatin, it grants competitive advantages such as high purity, reliable shelf stability, and rapid therapeutic action. Its use in chemotherapy ranks among the most effective protocols, ensuring improved patient outcomes and enhanced recovery potential in oncology practice.

Sample & Markets: Oxaltero Oxaliplatin 50mg Injection Overview

Oxaltero Oxaliplatin 50mg Injection samples are available for trial and clinical testing upon arrival of new shipments. With ongoing sale price competitiveness, the product has established a notable presence in the main export markets, particularly across Asia and Europe. Expenditure for bulk procurement remains reasonable, supporting large-scale supply within India's leading domestic networks. Timely delivery and efficient distribution uphold its reputation among hospitals and pharmaceutical retailers alike.

FAQ's of Oxaltero Oxaliplatin 50mg Injection:

Q: How should Oxaltero Oxaliplatin 50mg Injection be administered?

A: Oxaltero Oxaliplatin 50mg Injection is given intravenously under the supervision of a qualified healthcare professional, following precise dosing schedules prescribed for specific cancer types.

Q: What is the main benefit of using Oxaltero Oxaliplatin in cancer treatment?

A: The main benefit lies in its proven efficacy for treating various cancers, especially as part of chemotherapy regimens, offering improved outcomes and better response rates for patients.

Q: When is Oxaltero Oxaliplatin 50mg Injection typically prescribed?

A: It is typically prescribed during diagnosed cancer cases, particularly colorectal cancer, either as a standalone therapy or in combination with other treatments, based on clinical guidelines.

Q: Where can exporters and suppliers obtain Oxaltero Oxaliplatin 50mg Injection from India?

A: Exporters and suppliers may procure this product from established pharmaceutical manufacturers and authorized distributors based in India, ensuring compliance with safety and quality standards.

Q: What is the recommended process for storage and handling?

A: Oxaltero Oxaliplatin 50mg Injection should be stored in a cool and dry place, away from direct sunlight, and handled in accordance with medical guidelines to preserve its efficacy during the 12-month shelf life.

Q: How can healthcare professionals benefit from using this injection?

A: Healthcare professionals benefit by accessing a reliable cancer treatment that is supported by clinical studies, efficient distribution, and sample availability for evaluation before large-scale procurement.

Tell us about your requirement